Logo: to the web site of Uppsala University

The reduced effectiveness of chemotherapy in many patients undergoing treatment highlights the need for novel drug combinations that target drug resistance mechanisms contributing to tumor survival. Dynamic conditions within the tumor microenvironment influence the response to anti-cancer drugs. Accordingly, identifying effective drug concentrations and interactions (additive, synergistic, or antagonistic) in relevant tumor tissue models will inform new treatment combinations. To address this need for combinatorial chemotherapeutic (CTx) screening assays, we have developed a new assay called CombiCTx, which uses a device with three reservoirs containing gels loaded with anti-cancer drugs. The drug-loaded device is inverted and placed in a standard culture dish above cancer cells, and both are then enclosed in gel. Drugs diffuse from the reservoirs and expose cancer cells to overlapping dynamic drug gradients. We imaged diffusion of the anti-cancer drug doxorubicin in the assay using time-lapse microscopy, and established an imaging protocol for quantifying MDA-MB-231 breast cancer cell survival responses along drug gradients. Finally, evaluating combination effects of navitoclax and gemcitabine with CombiCTx revealed localized effects of navitoclax, attributed to limited diffusion, while gemcitabine seemed to diffuse readily throughout the assay and revealed a mild synergy in navitoclax affected regions. These data demonstrate the capacity of CombiCTx to evaluate the cytotoxic effects of anti-cancer drug combinations while accounting for drug diffusion differences, which is relevant in the context of the 3D tumor environment and may thereby help inform clinical treatment strategies.

Spinal implants have been successfully used to treat various spine conditions. However, concerns remain regarding the release of ions and particles that can cause adverse host responses. Moreover, the biological response from cells of the central nervous system to implant wear particles is not well documented. This research studied the interaction of silicon nitride, cobalt oxide, or chromium oxide particles with relevant glial cells, astrocytes and microglia, to assess their effects on viability and activation using a range of relevant concentrations. Astrocyte viability was not impaired by the particles, and expression levels of the astrocyte reactivity markers GFAP and vimentin were unaffected following 24 h of exposure. Moreover, the particles did not alter microglial phagocytic activity, or stimulate the release of the inflammatory cytokines TNF-α and IL-6. Together, these results suggest that the release of such particles from a spinal implant would not induce an inflammatory response in surrounding glial cells. Interestingly, high concentrations of SiN particles reduced microglial cell viability, potentially due to their tendency to form large agglomerates and/or their high dissolution rate. The present work highlights the importance of studying the potential effects of SiN particles on glial cells and encourages further investigations to fully understand the safety aspects of the use of SiN in spinal implants.

Light-triggered chemical reactions have demonstrated great potential for advanced cell guidance, on-demand release of therapeutics, and complex patterning in four dimensions. Current strategies rely on the cleavage of a light sensitive bond, while several protein and therapeutic release systems are designed using a hydrolytically labile bond. To bridge the gap between externally controlled light regulated transformations and intrinsically controlled hydrolytically labile bonds, a new family of light-triggered photocages that upon conjugation to target proteins form more or less hydrolytically (un)stable imine, hydrazone, and oxime bonds is reported. The three photocages follow a dose-dependent relationship using ultraviolet and near-infrared radiation and the one- and two-photon uncaging can be controlled in discrete volumes down to at least 10 µm precision. Upon photoirradiation, the exposed latent amino-, hydrazino-, and hydroxylamino-moieties readily react with a variety of proteins, and complimentary sustained release can be achieved. The relative release rate of imine-, hydrazone-, and oxime-bound proteins enable control over cell fate on hydrogels using two neuroblastoma cell lines. These results are anticipated to open new avenues for advanced materials where region-specifical degradability is central, such as for complex protein photopatterns, cell-guided hydrogels, and for programmable materials using photomediated dynamic covalent chemistry and photoclick chemistry.

Silicon nitride (SiN) coatings may reduce unwanted release of metal ions from metallic implants. However, as SiN slowly dissolves in aqueous solutions, additives that reduce this dissolution rate would likely increase the lifetime and functionality of implants. Adding iron (Fe) and carbon (C) permits tuning of the SiN coatings’ mechanical properties, but their effect on SiN dissolution rates, and their capacity to reduce metal ion release from metallic implant substrates, have yet to be investigated. Such coatings have recently been proposed for use in spinal implants; therefore, it is relevant to assess their impact on the viability of cells expected at the implant site, such as microglia, the resident macrophages of the central nervous system (CNS). To study the effects of Fe and C on the dissolution rate of SiN coatings, compositional gradients of Si, Fe and C in combination with N were generated by physical vapor deposition onto CoCrMo discs. Differences in composition did not affect the surface roughness or the release of Si, Fe or Co ions (the latter from the CoCrMo substrate). Adding Fe and C reduced ion release compared to a SiN reference coating, which was attributed to altered reactivity due to an increase in the fraction of stabilizing Si–C or Fe–C bonds. Extracts from the SiN coatings containing Fe and C were compatible with microglial viability in 2D cultures and 3D collagen hydrogels, to a similar degree as CoCrMo and SiN coated CoCrMo reference extracts. As Fe and C reduced the dissolution rate of SiN-coatings and did not compromise microglial viability, the capacity of these additives to extend the lifetime and functionality of SiN-coated metallic implants warrants further investigation.

Spinal implants have been used for decades to treat different spinal conditions. However, certain implant-related complications have been attributed to the release of particles and ions due to corrosion and wear triggering local immune responses including the release of pro-inflammatory cytokines, leading to local inflammation. The impact of these particles and ions on cells from the central nervous system (CNS) remains largely unknown, with few studies examining the effects on glial cells1. Indeed, the particles may migrate to adjacent nervous tissues and increasing our knowledge of the glial cell response is essential since they play a crucial role in maintaining tissue homeostasis and protecting the CNS. Most prior studies have used traditional 2D culture models; however, these lack the 3D spatial arrangement of cells found in tissues where they form important interactions with the extracellular matrix. The aim of this study was to employ an open source bioprinter2 to extrude hydrogels containing glial cells into which experimental implant debris can be introduced, enabling monitoring of cell viability and inflammatory responses by fluorescence microscopy. We have previously established that mono-cultures of microglia and astrocytes can be 3D cultured in collagen hydrogels, and their viability monitored using the caspase-3/7 apoptosis reporter and propidium iodide labelling for cell death. Applying a bioprinting strategy to produce these glial-laden constructs increases the reproducibility of these models, and allows the study of a wide range of types and concentrations of particles, resulting in a valuable tool to increase the knowledge about the biological response generated by particles from spinal implants.

Novel tumor-on-a-chip approaches are increasingly used to investigate tumor progression and potential treatment options. To improve the effect of any cancer treatment it is important to have an in depth understanding of drug diffusion, penetration through the tumor extracellular matrix and cellular uptake. In this study, we have developed a miniaturized chip where drug diffusion and cellular uptake in different hydrogel environments can be quantified at high resolution using live imaging. Diffusion of doxorubicin was reduced in a biomimetic hydrogel mimicking tissue properties of cirrhotic liver and early stage hepatocellular carcinoma (373 ± 108 µm2/s) as compared to an agarose gel (501 ± 77 µm2/s, p = 0.019). The diffusion was further lowered to 256 ± 30 µm2/s (p = 0.028) by preparing the biomimetic gel in cell media instead of phosphate buffered saline. The addition of liver tumor cells (Huh7 or HepG2) to the gel, at two different densities, did not significantly influence drug diffusion. Clinically relevant and quantifiable doxorubicin concentration gradients (1–20 µM) were established in the chip within one hour. Intracellular increases in doxorubicin fluorescence correlated with decreasing fluorescence of the DNA-binding stain Hoechst 33342 and based on the quantified intracellular uptake of doxorubicin an apparent cell permeability (9.00 ± 0.74 × 10–4 µm/s for HepG2) was determined. Finally, the data derived from the in vitro model were applied to a spatio-temporal tissue concentration model to evaluate the potential clinical impact of a cirrhotic extracellular matrix on doxorubicin diffusion and tumor cell uptake.

The primary cilium is an organelle present in most adult mammalian cells that is considered as an antenna for sensing the local microenvironment. Here, we use intact mouse pancreatic islets of Langerhans to investigate signaling properties of the primary cilium in insulin-secreting β-cells. We find that GABAB1 receptors are strongly enriched at the base of the cilium, but are mobilized to more distal locations upon agonist binding. Using cilia-targeted Ca2+ indicators, we find that activation of GABAB1 receptors induces selective Ca2+ influx into primary cilia through a mechanism that requires voltage-dependent Ca2+ channel activation. Islet β-cells utilize cytosolic Ca2+ increases as the main trigger for insulin secretion, yet we find that increases in cytosolic Ca2+ fail to propagate into the cilium, and that this isolation is largely due to enhanced Ca2+ extrusion in the cilium. Our work reveals local GABA action on primary cilia that involves Ca2+ influx and depends on restricted Ca2+ diffusion between the cilium and cytosol.